 |
 |
 |
|
- Glial Fibrillary Acidic Protein (GFAP) is a biomarker for intracerebral hemorrhage and ischemic stroke.
Citation for SK00257-01:
- Michel, M., Fiebich, B.L., Kuzior, H. et al. Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression. Transl Psychiatry 11, 308 (2021).
New GFAP Research References:
- Mattsson-Carlgren N, et al. Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease. Brain. 2021 Dec 16;144(11):3505-3516.
- Amalia L. Glial Fibrillary Acidic Protein (GFAP): Neuroinflammation Biomarker in Acute Ischemic Stroke. J Inflamm Res. 2021 Dec 30;14:7501-7506.
- Abdelhak A, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022 Mar;18(3):158-172
Citation for SK00257-01:
Michel, M., Fiebich, B.L., Kuzior, H. et al. Increased GFAP concentrations in the cerebrospinal fluid of patients with unipolar depression. Transl Psychiatry 11, 308 (2021). https://doi.org/10.1038/s41398-021-01423-6
|
|
|
 |
|
 |
|
